You are currently viewing a new version of our website. To view the old version click .
Molecules
  • Editor’s Choice
  • Review
  • Open Access

2 April 2025

The Role of Flow Chemistry on the Synthesis of Pyrazoles, Pyrazolines and Pyrazole-Fused Scaffolds

,
and
Associated Laboratory for Green Chemistry (LAQV) of the Network of Chemistry and Technology (REQUIMTE), Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
*
Authors to whom correspondence should be addressed.
This article belongs to the Special Issue Recent Advances in the Synthesis, Functionalization and Applications of Pyrazole-Type Compounds III

Abstract

Nitrogen-containing heterocycles are fundamental scaffolds in organic chemistry, particularly due to their prevalence in pharmaceuticals, agrochemicals and materials science. Among them, five-membered rings, containing two nitrogen atoms in adjacent positions—such as pyrazoles, pyrazolines and indazoles—are especially significant due to their versatile biological activities and structural properties, which led to the search for greener, faster and more efficient methods for their synthesis. Conventional batch synthesis methods, while effective, often face challenges related to reaction efficiency, scalability and safety. Flow chemistry has emerged as a powerful alternative, offering enhanced control over reaction parameters, improved safety profiles and opportunities for scaling up synthesis processes efficiently. This review explores the impact of flow chemistry on the synthesis of these pivotal heterocycles, highlighting its advantages over the conventional batch methods. Although indazoles have a five-membered ring fused with a benzene ring, they will also be considered in this review due to their biological relevance.

1. Introduction

The pyrazole moiety and related scaffolds are well-known in the pharmaceutical and medical fields as agrochemicals, and in materials science due to their structural and electronic properties, and biological activities, which are mainly analgesic, anti-inflammatory, anticancer, antioxidant and antifungal, among others [1,2,3,4]. Due to the increasing interest in this type of compound, a broad range of synthetic methods has been developed and described over the years. In 2023, Hasani and coworkers published a review on methods for the synthesis of pyrazoles [5]. However, the most common methods—batch methods—while effective, present some major issues such as long reaction times; lack of selectivity; and, in some cases, low yield and safety concerns, thus urging researchers to develop safer and more efficient processes [6,7]. Flow chemistry, also known as continuous flow processing, involves performing chemical reactions in a continuously flowing stream rather than in a static batch reactor [8]. Thus, flow chemistry has become a compelling alternative due to its key advantages, which include (i) enhanced reaction control, meaning that a precise control over temperature, pressure and reaction time is possible; (ii) safety, because it allows a better management of exothermic and hazardous reactions; (iii) scalability, facilitating the transition from laboratory to industrial scale; and (iv) efficiency, as it allows a significant reduction in reaction time and improvement in reaction yield [9,10].
These features make flow chemistry particularly suited for synthesizing more complex molecules, such as nitrogen-containing heterocycles. In the next sections, relevant examples of the application of flow chemistry in the synthesis of pyrazoles, pyrazolines and indazoles, reported in the last ten years, will be presented. It is noteworthy that only fifteen publications (research papers and reviews) were found for this period of time, whilst for the flow synthesis of indazoles, only three papers were reported. These numbers show that there is space for further development of research in this area.

2. Pyrazoles, Pyrazolines and Fused Scaffolds

Pyrazoles 1 are a family of aromatic heterocyclic compounds characterized by a five-membered ring constituted by three carbons and two adjacent nitrogen atoms, located at 1- and 2-positions [11,12]. N-Unsubstituted pyrazoles often exhibit three identical and inseparable tautomeric forms, owing to rapid interconversion in solution, making it typically challenging to definitively assign the proton resonances of the pyrazole core in proton nuclear magnetic resonance (1H NMR) spectra. Three partially reduced forms—1-pyrazoline 2, 2-pyrazoline 3 and 3-pyrazoline 4—may also exist, as well as a fully reduced form known as pyrazolidine 5 (Figure 1) [13].
Figure 1. Chemical structures and numbering of pyrazole 1, dihydropyrazole (pyrazoline) tautomers 24 and pyrazolidine 5.
Additionally, the pyrazole core can be fused with other rings—for example, benzene, pyrimidone and pyridine rings—to form indazole 6, pyrazolopyrimidinone 7 and pyrazolopyridine 8 scaffolds, respectively (Figure 2). Recent reviews by Mal et al., and Xu and colleagues, gather all the information regarding biological properties and applications of these pyrazole hybrids, highlighting the fact that some commercial drugs already incorporate these scaffolds in their structure [14,15].
Figure 2. Chemical structures of indazole 6, pyrazolopyrimidinone 7 and pyrazolopyridine 8 scaffolds.
The increasing interest that pyrazoles and their related derivatives (pyrazolines and indazoles)—both natural and synthetic analogues—have been receiving over the years is due to their various pharmacological properties such as anticancer, analgesic, anti-inflammatory, antioxidant, antibacterial, antifungal, antipyretic, antidepressant, anticonvulsant, antidiabetic and cannabinoid activities, among others [16,17,18,19,20,21,22,23,24]. In fact, the pyrazole scaffold and its derivatives are present in several known drugs, such as celecoxib (Celebrex®), sildenafil (Viagra®), rimonabant, lonazolac, fomepizole, penthiopyrad, doramapimod, sulfaphenazole, lonidamine and bendazac. Furthermore, these N-heterocycles can easily form bonds with a variety of enzymes and receptors in biological targets due to their ability to form various weak interactions and π-stacking, which is the reason why they are key scaffolds in the field of medicinal chemistry [25]. On the other hand, the electronic properties of pyrazoles and pyrazolines—their intrinsic fluorescence, crystal structures and solid-state properties—make them valuable in various materials science applications such as in fluorescent probes and sensors; optoelectronic, photoluminescent and energetic materials; as organic fluorophores based on small molecules; and as dyes, among other applications [26,27,28,29,30,31].

2.1. Synthesis of Pyrazoles and Pyrazolines

Several methods for the synthesis of pyrazoles have been developed and described over the years, with the most employed or classical ones being (a) cyclocondensation of carbonyl compounds 912 with hydrazine derivatives 13 (Scheme 1); (b) multicomponent reactions (Scheme 2); and (c) 1,3-dipolar cycloadditions of sydnones (Scheme 3), nitrilimines (Scheme 4) or diazo compounds (Scheme 5). These methods were described in detail in a recent review [5,32,33,34,35].
Scheme 1. Cyclocondensation of carbonyl compounds 912 with hydrazine derivatives 13.
Scheme 2. Multicomponent synthesis of pyrazoles.
Scheme 3. 1,3-Dipolar cycloaddition of sydnones with carbonyl compounds.
Scheme 4. 1,3-Dipolar cycloaddition of nitrilimines with terminal alkynes.
Scheme 5. 1,3-Dipolar cycloaddition of diazo compounds with terminal alkynes.

2.2. Synthesis of Indazoles

When it comes to the synthesis of indazoles, the most common strategies are (a) diazotization of o-alkyl-substituted anilines 27, (b) condensation of o-substituted carbonyl compounds 28 with hydrazine derivatives 13, (c) [3 + 2] cyclization of benzynes 29 with diazomethanes 31 and (d) transition-metal-catalyzed intramolecular amination of o-haloarylhydrazones 30 or direct C–H amination of arylhydrazones (Scheme 6) [36,37,38].
Scheme 6. Common strategies for the synthesis of N-aryl-1H-indazoles 32.
Although these N-heterocyclic compounds have been deeply studied in the last few years, the truth is that most of the synthetic approaches developed to achieve pyrazoles and pyrazole derivatives still require improvements, especially in terms of increases in the yields, regioselectivity and up-scaling. Moreover, the handling of hazardous materials and intermediates imposes a major obstacle, not only due to the risk of exposure but also because it limits the available functional groups and, consequently, the number of derivatives. Thus, it is crucial to develop more efficient and safer methods for the synthesis of pyrazoles and pyrazole derivatives [39]. In this line of thought, flow chemistry has been pointed out as a viable alternative over batch methods.

3. Principles of Flow Chemistry

The field of flow chemistry has been growing over the last years, due to its major advantages and applications in the context of Green Chemistry towards the development of more sustainable synthetic approaches. This concept is based on a continuous stream of different starting materials, which are introduced by pumps or syringes and mixed in a continuous reactor. Rigorous control of both temperature and pressure, as well as the flow rate of each reagent and/or mixture, is possible when using this methodology, improving reactions’ efficiency and reproducibility [40]. Additionally, enhanced mass and heat transfer, and reduced energy consumption and waste formation, are two other important advantages, making flow chemistry a greener method [41]. Products are usually obtained with higher yield and selectivity when compared to batch conditions, increasing product quality. Another major benefit of reactions under flow conditions is the ability to handle and generate hazardous and/or toxic intermediates in situ, avoiding workups of such compounds and therefore improving environmental protection and operator safety. Furthermore, there is no accumulation of considerable amounts of dangerous compounds since the flow process does not require high reaction volumes (Figure 3). While offering these advantages, flow chemistry also presents technical challenges that need to be addressed for its widespread adoption. For example, achieving uniform mixing in continuous flow systems can sometimes be challenging, especially for reactions that require precise control of reactant distribution, leading to variations in product yield and selectivity. Another problem can be the difficulty in maintaining optimal reaction temperatures for highly exothermic or endothermic reactions. Inadequate heat transfer control can lead to hot spots, thermal degradation or formation of by-products. Also, precipitation of solids, polymerization or deposition of reaction by-products can clog microreactors. Finally, multi-phase, gas–liquid and liquid–solid reactions may be more difficult to handle, requiring specialized reactor designs to ensure efficient contact between phases. Likewise, reactions involving long residence times or specific catalysts may not be well-suited for continuous flow (Figure 3). To overcome these difficulties, tailored reactor designs or hybrid batch–flow approaches may be necessary. Interdisciplinary collaborations between chemists and engineers to surpass these obstacles have contributed to the development of innovative reactors, control systems and process optimization, boosting the development of flow chemistry.
Figure 3. Principles, advantages and limitations of flow chemistry.

5. Challenges and Future Directions

While flow chemistry offers numerous advantages, challenges remain concerning the reactors’ design to ensure that diffusion rates do not limit reaction rates, and especially the development of specialized reactors for heterogeneous reactions and solid-phase synthesis. Another difficulty still to be overcome is the management of side reactions in multi-component systems. In-line process analysis can be particularly important in these reactions for real-time monitoring of reaction parameters and products formed. Also, downstream processes—namely, streamlining separation, purification and isolation steps—must be seamlessly integrated with flow reactions. Techniques such as membrane filtration, crystallization and liquid–liquid extraction need to be optimized for continuous operation. Future directions in this research area comprise reaction automatization and the development of better modular flow systems for multi-step synthesis of complex heterocycles.
Despite its advantages, flow chemistry still faces economic barriers that hinder its widespread adoption. These include the high initial investment cost, due to the need for specialized equipment (flow reactors, pumps, microreactors and automation systems) that are expensive compared to traditional batch reactors, and flow implementation may require modifications in the existing laboratory or industrial setups. Also, reaction conditions (temperature, pressure and residence time) must be carefully optimized, which can be costly. The integration of flow reactors with existing systems, namely, batch systems, may be complex and expensive. On the other hand, flow systems require periodic cleaning due to reactor fouling and clogging; frequent maintenance; and replacement of components like tubing, pump and reactors, thus increasing costs. These costs and technical issues may explain the existing reluctance in shifting from batch to flow. To expand the implementation of flow chemistry, training future generations of chemists and engineers to operate flow chemistry systems is also essential as it demands specialized knowledge in fluid dynamics, automation and reactor design.

6. Conclusions

The interest in the pivotal heterocyclic compounds reported in this review—pyrazoles, pyrazolines and fused pyrazoles—has been growing owing to their relevance in the pharmaceutical, agrochemical and materials science fields. However, the conventional methods for their synthesis present some obstacles regarding selectivity, scalability and safety. Flow chemistry has revolutionized the synthesis of five-membered nitrogen-containing heterocycles. The examples discussed in this monography showed that the application of flow chemistry in the synthesis of pyrazoles, pyrazolines and indazoles was particularly important to address limitations of traditional methods enabling the development of more efficient, scalable and environmentally friendly processes. As advancements in reactor technology and process integration continue, the role of flow chemistry in the synthesis of these important heterocycles is expected to expand further, paving the way for innovative applications in pharmaceuticals and materials development.

Author Contributions

Conceptualization, C.M.C. and V.L.M.S.; validation, A.M.S.S. and V.L.M.S.; Investigation, C.M.C.; writing—original draft preparation, C.M.C.; writing—review and editing, C.M.C., A.M.S.S. and V.L.M.S.; supervision, A.M.S.S. and V.L.M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by PT national funds (FCT/MCTES, Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior) through the project UID/50006-Laboratório Associado para a Química Verde—Tecnologias e Processos Limpos (LAQV/REQUIMTE), and the PhD grant 2022.11584.BD.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data sharing is not applicable.

Acknowledgments

Catarina M. Correia thanks FCT/MCTES (Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior) for her PhD grant 2022.11584.BD.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BPRBack pressure regulator
BnBenzyl
BuButyl
BzBenzoyl
catCatalyst
DCE1,2-Dichloroethane
DCMDichloromethane
DIEAN,N-Diisopropylethylamine
DMFDimethylformamide
DMSODimethylsulfoxide
equivMolar equivalent
EtEthyl
EVI2Ethyl viologen diiodide
EWGElectron withdrawing group
FEPFluorinated ethylene-propylene
1H NMRProton nuclear magnetic resonance spectroscopy
iBuiso-Butyl
iPriso-Propyl
IRInfrared
LEDLight emitting diode
MeMethyl
MWMicrowave
NMPN-Methyl-2-pyrrolidone
PDE-5Phosphodiesterase 5
PFAPerfluoroalkoxy
PhPhenyl
PTFEPolytetrafluoroethylene
p-TSApara-Toluenesulfonic acid
r.tRoom temperature
SGOSulfonated graphene oxide
iBut-Butyl
TFATrifluoroacetic acid
THFTetrahydrofuran
TLRToll-like receptor
TMEDAN,N,N’,N’-Tetramethylethylenediamine
TMSTetramethylsilane
tRResidence time

References

  1. Kumar, V.; Kaur, K.; Gupta, G.K.; Sharma, A.K. Pyrazole Containing Natural Products: Synthetic Preview and Biological Significance. Eur. J. Med. Chem. 2013, 69, 735–753. [Google Scholar] [CrossRef] [PubMed]
  2. Ebenezer, O.; Shapi, M.; Tuszynski, J.A. A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives. Biomedicines 2022, 10, 1124. [Google Scholar] [CrossRef]
  3. Ahsan, M.J.; Ali, A.; Ali, A.; Thiriveedhi, A.; Bakht, M.A.; Yusuf, M.; Salahuddin; Afzal, O.; Altamimi, A.S.A. Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders. ACS Omega 2022, 7, 38207–38245. [Google Scholar] [CrossRef] [PubMed]
  4. Puri, S.; Sawant, S.; Juvale, K. A Comprehensive Review on the Indazole Based Derivatives as Targeted Anticancer Agents. J. Mol. Struct. 2023, 1284, 135327. [Google Scholar] [CrossRef]
  5. Hassani, I.A.E.; Rouzi, K.; Assila, H.; Karrouchi, K.; Ansar, M. Recent Advances in the Synthesis of Pyrazole Derivatives: A Review. Reactions 2023, 4, 478–504. [Google Scholar] [CrossRef]
  6. Capaldo, L.; Wen, Z.; Noël, T. A Field Guide to Flow Chemistry for Synthetic Organic Chemists. Chem. Sci. 2023, 14, 4230–4247. [Google Scholar] [CrossRef] [PubMed]
  7. Wu, J.; Yang, X.; Pan, Y.; Zuo, T.; Ning, Z.; Li, C.; Zhang, Z. Recent Developments of Automated Flow Chemistry in Pharmaceutical Compounds Synthesis. J. Flow Chem. 2023, 13, 385–404. [Google Scholar] [CrossRef]
  8. Cherkasov, N.; Adams, S.J.; Bainbridge, E.G.A.; Thornton, J.A.M. Continuous Stirred Tank Reactors in Fine Chemical Synthesis for Efficient Mixing, Solids-Handling, and Rapid Scale-Up. React. Chem. Eng. 2023, 8, 266–277. [Google Scholar] [CrossRef]
  9. Plutschack, M.B.; Pieber, B.; Gilmore, K.; Seeberger, P.H. The Hitchhiker’s Guide to Flow Chemistry. Chem. Rev. 2017, 117, 11796–11893. [Google Scholar] [CrossRef]
  10. Laybourn, A.; Robertson, K.; Slater, A.G. Quid Pro Flow. J. Am. Chem. Soc. 2023, 145, 4355–4365. [Google Scholar] [CrossRef]
  11. Abrigach, F.; Touzani, R. Pyrazole Derivatives with NCN Junction and Their Biological Activity: A Review. Med. Chem. 2016, 6, 292–298. [Google Scholar] [CrossRef]
  12. Alam, J.; Alam, O.; Alam, P.; Naim, M.J. A Review on Pyrazole Chemical Entity and Biological Activity. Int. J. Pharm. Sci. Res. 2015, 6, 1433–1442. [Google Scholar]
  13. Gomes, P.M.O.; Ouro, P.M.S.; Silva, A.M.S.; Silva, V.L.M. Styrylpyrazoles: Properties, Synthesis and Transformations. Molecules 2020, 25, 5886. [Google Scholar] [CrossRef]
  14. Mal, S.; Malik, U.; Mahapatra, M.; Mishra, A.; Pal, D.; Paidesetty, S.K. A Review on Synthetic Strategy, Molecular Pharmacology of Indazole Derivatives, and Their Future Perspective. Drug Dev. Res. 2022, 83, 1469–1504. [Google Scholar] [CrossRef] [PubMed]
  15. Xu, Z.; Zhuang, Y.; Chen, Q. Current Scenario of Pyrazole Hybrids with in Vivo Therapeutic Potential against Cancers. Eur. J. Med. Chem. 2023, 257, 115495. [Google Scholar] [CrossRef]
  16. Silva, V.L.M.; Silva, A.M.S.; Pinto, D.C.G.A.; Rodríguez, P.; Gómez, M.; Jagerovic, N.; Callado, L.F.; Cavaleiro, J.A.S.; Elguero, J.; Fernández-Ruiz, J. Synthesis and Pharmacological Evaluation of New (E)- and (Z)-3-Aryl-4-Styryl-1H-Pyrazoles as Potential Cannabinoid Ligands. Arkivoc 2010, 2010, 226–247. [Google Scholar] [CrossRef]
  17. Abdel-Maksoud, M.S.; El-Gamal, M.I.; Gamal El-Din, M.M.; Oh, C.H. Design, Synthesis, in Vitro Anticancer Evaluation, Kinase Inhibitory Effects, and Pharmacokinetic Profile of New 1,3,4-Triarylpyrazole Derivatives Possessing Terminal Sulfonamide Moiety. J. Enzyme Inhib. Med. Chem. 2019, 34, 97–109. [Google Scholar] [CrossRef] [PubMed]
  18. Amir, M.; Kumar, S. Synthesis and Anti-Inflammatory, Analgesic, Ulcerogenic and Lipid Peroxidation Activities of 3,5-Dimethyl Pyrazoles, 3-Methyl Pyrazol-5-ones and 3,5-Disubstituted Pyrazolines. Indian J. Chem. 2005, 44, 2532–2537. [Google Scholar] [CrossRef]
  19. Bekhit, A.A.; Nasralla, S.N.; El-Agroudy, E.J.; Hamouda, N.; El-Fattah, A.A.; Bekhit, S.A.; Amagase, K.; Ibrahim, T.M. Investigation of the Anti-Inflammatory and Analgesic Activities of Promising Pyrazole Derivative. Eur. J. Pharm. Sci. 2022, 168, 106080. [Google Scholar] [CrossRef]
  20. Silva, V.L.M.; Elguero, J.; Silva, A.M.S. Current Progress on Antioxidants Incorporating the Pyrazole Core. Eur. J. Med. Chem. 2018, 156, 394–429. [Google Scholar] [CrossRef] [PubMed]
  21. Chowdary, B.N.; Umashankara, M.; Dinesh, B.; Girish, K.; Baba, A.R. Development of 5-(Aryl)-3-Phenyl-1H-Pyrazole Derivatives as Potent Antimicrobial Compounds. Asian J. Chem. 2019, 31, 45–50. [Google Scholar] [CrossRef]
  22. Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S. The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents. Curr. Med. Chem. 2011, 18, 5114–5144. [Google Scholar] [CrossRef] [PubMed]
  23. Datar, P. Development of Pyrazole Compounds as Antidiabetic Agent: A Review. Drug Des. Discov. 2014, 11, 686–703. [Google Scholar] [CrossRef]
  24. Silva, V.L.M.; Silva, A.M.S.; Pinto, D.C.G.A.; Jagerovic, N.; Callado, L.F.; Cavaleiro, J.A.S.; Elguero, J. Synthesis and Pharmacological Evaluation of Chlorinated N-Alkyl-3- and -5-(2-Hydroxyphenyl)Pyrazoles as CB1 Cannabinoid Ligands. Monatsh. Chem. 2007, 138, 797–811. [Google Scholar] [CrossRef]
  25. Chernyshov, V.V.; Popadyuk, I.I.; Yarovaya, O.I.; Salakhutdinov, N.F. Nitrogen-Containing Heterocyclic Compounds Obtained from Monoterpenes or Their Derivatives: Synthesis and Properties. Top. Curr. Chem. 2022, 380, 42. [Google Scholar] [CrossRef]
  26. Varghese, B.; Al-Busafi, S.N.; Suliman, F.O.; Al-Kindy, S.M.Z. Unveiling a Versatile Heterocycle: Pyrazoline—A Review. RSC Adv. 2017, 7, 46999–47016. [Google Scholar] [CrossRef]
  27. Noori, Z.; Solà, M.; Viñas, C.; Teixidor, F.; Poater, J. Unraveling Aromaticity: The Dual Worlds of Pyrazole, Pyrazoline, and 3D Carborane. Beilstein J. Org. Chem. 2025, 21, 412–420. [Google Scholar] [CrossRef] [PubMed]
  28. Jin, M.; Liang, Y.J.; Lu, R.; Chuai, X.H.; Yi, Z.H.; Zhao, Y.; Zhang, H.J. Synthesis and Properties of Photoluminescence and Electroluminescence of Pyrazoline Derivatives. Synth. Met. 2004, 140, 37–41. [Google Scholar] [CrossRef]
  29. Portilla, J. Current Advances in Synthesis of Pyrazole Derivatives: An Approach Toward Energetic Materials. J. Heterocycl. Chem. 2024, 61, 2026–2039. [Google Scholar] [CrossRef]
  30. Lee, B.H.; Jaung, J.Y.; Jang, S.C.; Yi, S.C. Synthesis and Optical Properties of Push–Pull Type Tetrapyrazinoporphyrazines. Dyes Pigm. 2005, 65, 159–167. [Google Scholar] [CrossRef]
  31. Secrieru, A.; O’Neill, P.M.; Cristiano, M.L.S. Revisiting the Structure and Chemistry of 3(5)-Substituted Pyrazoles. Molecules 2019, 25, 42. [Google Scholar] [CrossRef] [PubMed]
  32. Chen, J.; Chen, D.; Kuang, J.; Ma, Y. Transition Metal-Free De Novo Synthesis of Sulfonated Pyrazoles from Sulfonyl Hydrazides, 1,3-Diketones, and Sodium Sulfinates at Room Temperature. J. Org. Chem. 2021, 86, 9289–9298. [Google Scholar] [CrossRef] [PubMed]
  33. Lakeland, C.P.; Watson, D.W.; Harrity, J.P.A. Exploiting Synergistic Catalysis for an Ambient Temperature Photocycloaddition to Pyrazoles. Chem. Eur. J. 2020, 26, 155. [Google Scholar] [CrossRef] [PubMed]
  34. Han, T.; Wang, K.-H.; Yang, M.; Zhao, P.; Wang, F.; Wang, J.; Huang, D.; Hu, Y. Synthesis of Difluoromethylated Pyrazoles by the [3 + 2] Cycloaddition Reaction of Difluoroacetohydrazonoyl Bromides. J. Org. Chem. 2022, 87, 498–511. [Google Scholar] [CrossRef]
  35. Zhao, P.; Zeng, Z.; Feng, X.; Liu, X. Multisubstituted Pyrazole Synthesis via [3 + 2] Cycloaddition/Rearrangement/N-H Insertion Cascade Reaction of α-Diazoesters and Ynones. Chin. Chem. Lett. 2021, 32, 132–135. [Google Scholar] [CrossRef]
  36. Song, J.J.; Yee, N.K. A Novel Synthesis of 2-Aryl-2H-Indazoles via a Palladium-Catalyzed Intramolecular Amination Reaction. Org. Lett. 2000, 2, 519–521. [Google Scholar] [CrossRef]
  37. Batt, D.G.; Petraitis, J.J.; Houghton, G.C.; Modi, D.P.; Cain, G.A.; Corjay, M.H.; Mousa, S.A.; Bouchard, P.J.; Forsythe, M.S.; Harlow, P.P.; et al. Disubstituted Indazoles as Potent Antagonists of the Integrin Avβ3. J. Med. Chem. 2000, 43, 41–58. [Google Scholar] [CrossRef]
  38. Wu, C.; Fang, Y.; Larock, R.C.; Shi, F. Synthesis of 2H-Indazoles by the [3 + 2] Cycloaddition of Arynes and Sydnones. Org. Lett. 2010, 12, 2234–2237. [Google Scholar] [CrossRef] [PubMed]
  39. Ríos, M.-C.; Portilla, J. Recent Advances in Synthesis and Properties of Pyrazoles. Chemistry 2022, 4, 940–968. [Google Scholar] [CrossRef]
  40. Rogers, L.; Jensen, K.F. Continuous Manufacturing—The Green Chemistry Promise? Green Chem. 2019, 21, 3481–3498. [Google Scholar] [CrossRef]
  41. Dallinger, D.; Kappe, C.O. Why Flow Means Green—Evaluating the Merits of Continuous Processing in the Context of Sustainability. Curr. Opin. Green Sust. 2017, 7, 6–12. [Google Scholar] [CrossRef]
  42. Das, A.; Ishitani, H.; Kobayashi, S. Toward Continuous-Flow Synthesis of Biologically Interesting Pyrazole Derivatives. Adv. Synth. Catal. 2019, 361, 5127–5132. [Google Scholar] [CrossRef]
  43. Audubert, C.; Gamboa Marin, O.J.; Lebel, H. Batch and Continuous-Flow One-Pot Processes Using Amine Diazotization to Produce Silylated Diazo Reagents. Angew. Chem. Int. Ed. 2017, 56, 6294–6297. [Google Scholar] [CrossRef] [PubMed]
  44. Ötvös, S.B.; Georgiádes, Á.; Ozsvár, D.; Fülöp, F. Continuous-Flow Synthesis of 3,5-Disubstituted Pyrazoles via Sequential Alkyne Homocoupling and Cope-Type Hydroamination. RSC Adv. 2019, 9, 8197–8203. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, L.; Yu, X.; Feng, X.; Bao, M. Synthesis of 3,5-Disubstituted Pyrazoles via Cope-Type Hydroamination of 1,3-Dialkynes. J. Org. Chem. 2013, 78, 1693–1698. [Google Scholar] [CrossRef] [PubMed]
  46. Paquin, P.; DeGrâce, N.; Bélanger-Chabot, G.; Paquin, J.-F. Synthesis of Substituted Pentafluorosulfanylpyrazoles Under Flow Conditions. J. Org. Chem. 2024, 89, 3552–3562. [Google Scholar] [CrossRef]
  47. Kandasamy, M.; Ganesan, B.; Hung, M.; Lin, W. Fast and Efficient Continuous Flow Method for the Synthesis of Ynones and Pyrazoles. Eur. J. Org. Chem. 2019, 2019, 3183–3189. [Google Scholar] [CrossRef]
  48. Burke, A.; Spiccio, S.; Di Filippo, M.; Baumann, M. Photochemical Synthesis of Pyrazolines from Tetrazoles in Flow. SynOpen 2023, 7, 69–75. [Google Scholar] [CrossRef]
  49. Burke, A.; Di Filippo, M.; Spiccio, S.; Schito, A.M.; Caviglia, D.; Brullo, C.; Baumann, M. Antimicrobial Evaluation of New Pyrazoles, Indazoles and Pyrazolines Prepared in Continuous Flow Mode. Int. J. Mol. Sci. 2023, 24, 5319. [Google Scholar] [CrossRef]
  50. Luo, J.; Zhou, Q.; Xu, Z.; Houk, K.N.; Zheng, K. Photochemical Skeletal Editing of Pyridines to Bicyclic Pyrazolines and Pyrazoles. J. Am. Chem. Soc. 2024, 146, 21389–21400. [Google Scholar] [CrossRef]
  51. Battilocchio, C.; Deadman, B.J.; Nikbin, N.; Kitching, M.O.; Baxendale, I.R.; Ley, S.V. A Machine-Assisted Flow Synthesis of SR48692: A Probe for the Investigation of Neurotensin Receptor-1. Chem. Eur. J. 2013, 19, 7917–7930. [Google Scholar] [CrossRef]
  52. Poh, J.-S.; Browne, D.L.; Ley, S.V. A Multistep Continuous Flow Synthesis Machine for the Preparation of Pyrazoles via a Metal-Free Amine-Redox Process. React. Chem. Eng. 2016, 1, 101–105. [Google Scholar] [CrossRef] [PubMed]
  53. Groves, L.M.; Schotten, C.; Beames, J.; Platts, J.A.; Coles, S.J.; Horton, P.N.; Browne, D.L.; Pope, S.J.A. From Ligand to Phosphor: Rapid, Machine-Assisted Synthesis of Substituted Iridium(III) Pyrazolate Complexes with Tuneable Luminescence. Chem. Eur. J. 2017, 23, 9407–9418. [Google Scholar] [CrossRef] [PubMed]
  54. Li, B.; Widlicka, D.; Boucher, S.; Hayward, C.; Lucas, J.; Murray, J.C.; O’Neil, B.T.; Pfisterer, D.; Samp, L.; VanAlsten, J.; et al. Telescoped Flow Process for the Syntheses of N-Aryl Pyrazoles. Org. Process Res. Dev. 2012, 16, 2031–2035. [Google Scholar] [CrossRef]
  55. Scholtz, C.; Riley, D.L. Improved Batch and Flow Syntheses of the Nonsteroidal Anti-Inflammatory COX-2 Inhibitor Celecoxib. React. Chem. Eng. 2021, 6, 138–146. [Google Scholar] [CrossRef]
  56. Comas-Barceló, J.; Blanco-Ania, D.; Van Den Broek, S.A.M.W.; Nieuwland, P.J.; Harrity, J.P.A.; Rutjes, F.P.J.T. Cu-Catalysed Pyrazole Synthesis in Continuous Flow. Catal. Sci. Technol. 2016, 6, 4718–4723. [Google Scholar] [CrossRef]
  57. Mertens, L.; Hock, K.J.; Koenigs, R.M. Fluoroalkyl-Substituted Diazomethanes and Their Application in a General Synthesis of Pyrazoles and Pyrazolines. Chem. Eur. J. 2016, 22, 9542–9545. [Google Scholar] [CrossRef] [PubMed]
  58. Britton, J.; Jamison, T.F. A Unified Continuous Flow Assembly-Line Synthesis of Highly Substituted Pyrazoles and Pyrazolines. Angew. Chem. Int. Ed. 2017, 56, 8823–8827. [Google Scholar] [CrossRef] [PubMed]
  59. Duffy, M.; Di Filippo, M.; Baumann, M. Synthesis of 2H-Indazoles via the Cadogan Reaction in Batch and Flow Mode. Tetrahedron Lett. 2021, 86, 153522. [Google Scholar] [CrossRef]
  60. Bracken, C.; Batsanov, A.S.; Baumann, M. Development of a Continuous Photochemical Benzyne-Forming Process. SynOpen 2021, 5, 29–35. [Google Scholar] [CrossRef]
  61. Fang, Y.; Wu, C.; Larock, R.C.; Shi, F. Synthesis of 2H-Indazoles by the [3 + 2] Dipolar Cycloaddition of Sydnones with Arynes. J. Org. Chem. 2011, 76, 8840–8851. [Google Scholar] [CrossRef]
  62. Lehmann, H.; Ruppen, T.; Knoepfel, T. Scale-Up of Diazonium Salts and Azides in a Three-Step Continuous Flow Sequence. Org. Process Res. Dev. 2022, 26, 1308–1317. [Google Scholar] [CrossRef]
  63. Shaaban, M.A.; Elshaier, Y.A.M.M.; Hammad, A.H.; Farag, N.A.; Hassan Haredy, H.; AbdEl-Ghany, A.A.; Mohamed, K.O. Design and Synthesis of Pyrazolo[3,4-d]Pyrimidinone Derivatives: Discovery of Selective Phosphodiesterase-5 Inhibitors. Bioorg. Med. Chem. Lett. 2020, 30, 127337. [Google Scholar] [CrossRef]
  64. Tageldin, G.N.; Ibrahim, T.M.; Fahmy, S.M.; Ashour, H.M.; Khalil, M.A.; Nassra, R.A.; Labouta, I.M. Synthesis, Modeling and Biological Evaluation of Some Pyrazolo[3,4-d]Pyrimidinones and Pyrazolo[4,3-e][1,2,4]Triazolo[4,3-a]Pyrimidinones as Anti-Inflammatory Agents. Bioorg. Chem. 2019, 90, 102844. [Google Scholar] [CrossRef]
  65. Abdellatif, K.; Abdelall, E.; Abdelgawad, M.; Ahmed, R.; Bakr, R. Synthesis and Anticancer Activity of Some New Pyrazolo[3,4-d]Pyrimidin-4-One Derivatives. Molecules 2014, 19, 3297–3309. [Google Scholar] [CrossRef] [PubMed]
  66. Beyzaei, H.; Aryan, R.; Moghaddam-Manesh, M.; Ghasemi, B.; Karimi, P.; Samareh Delarami, H.; Sanchooli, M. Evaluation and Structure-Activity Relationship Analysis of a New Series of 4-Imino-5H-Pyrazolo[3,4-d]Pyrimidin-5-Amines as Potential Antibacterial Agents. J. Mol. Struct. 2017, 1144, 273–279. [Google Scholar] [CrossRef]
  67. Sagar, S.R.; Agarwal, J.K.; Pandya, D.H.; Dash, R.P.; Nivsarkar, M.; Vasu, K.K. Design, Synthesis and Biological Evaluation of Novel Pyrazolo-Pyrimidinones as DPP-IV Inhibitors in Diabetes. Bioorg. Med. Chem. Lett. 2015, 25, 4428–4433. [Google Scholar] [CrossRef] [PubMed]
  68. El-Mekabaty, A.; Etman, H.A.; Mosbah, A.; Fadda, A.A. Synthesis, In Vitro Cytotoxicity and Bleomycin-Dependent DNA Damage Evaluation of Some Heterocyclic-Fused Pyrimidinone Derivatives. ChemistrySelect 2020, 5, 4856–4861. [Google Scholar] [CrossRef]
  69. Bruzziches, R.; Francomano, D.; Gareri, P.; Lenzi, A.; Aversa, A. An Update on Pharmacological Treatment of Erectile Dysfunction with Phosphodiesterase Type 5 Inhibitors. Expert Opin. Pharmacother. 2013, 14, 1333–1344. [Google Scholar] [CrossRef]
  70. Lee, S.S.; Oh, C.H. Synthesis of Sildenafil and Its Derivatives Bearing Pyrazolo-pyrimidinones Scaffold. Bull. Korean Chem. Soc. 2024, 45, 759–763. [Google Scholar] [CrossRef]
  71. Sthalam, V.K.; Mahajan, B.; Karra, P.R.; Singh, A.K.; Pabbaraja, S. Sulphonated Graphene Oxide Catalyzed Continuous Flow Synthesis of Pyrazolo Pyrimidinones, Sildenafil and Other PDE-5 Inhibitors. RSC Adv. 2022, 12, 326–330. [Google Scholar] [CrossRef] [PubMed]
  72. Donaire-Arias, A.; Montagut, A.M.; Puig De La Bellacasa, R.; Estrada-Tejedor, R.; Teixidó, J.; Borrell, J.I. 1H-Pyrazolo[3,4-b]Pyridines: Synthesis and Biomedical Applications. Molecules 2022, 27, 2237. [Google Scholar] [CrossRef] [PubMed]
  73. O’Brien, A.G.; Lévesque, F.; Seeberger, P.H. Continuous Flow Thermolysis of Azidoacrylates for the Synthesis of Heterocycles and Pharmaceutical Intermediates. Chem. Commun. 2011, 47, 2688–2690. [Google Scholar] [CrossRef] [PubMed]
  74. Tsoung, J.; Bogdan, A.R.; Kantor, S.; Wang, Y.; Charaschanya, M.; Djuric, S.W. Synthesis of Fused Pyrimidinone and Quinolone Derivatives in an Automated High-Temperature and High-Pressure Flow Reactor. J. Org. Chem. 2017, 82, 1073–1084. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.